共 50 条
- [24] Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
- [26] A novel doxorubicin/CTLA-4 blocker co-loaded drug delivery system improves efficacy and safety in antitumor therapy [J]. CELL DEATH & DISEASE, 2024, 15 (06):
- [28] Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer [J]. CANCER MEDICINE, 2024, 13 (09):
- [30] Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4), and CD137 in cervical carcinoma [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (10): : 1038 - +